Results 241 to 250 of about 27,710,413 (387)
A Humanizing Rewrite for CAR T Cells in Autoimmune Disease: A StepToward Repeatable, Durable Therapy
Samia Chergui
openalex +2 more sources
Developing in vitro expanded CD45RA+regulatory T cells as an adoptive cell therapy for Crohn's disease [PDF]
James B. Canavan +20 more
openalex +1 more source
Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici +8 more
wiley +1 more source
CAR-T cells immunotherapy in the treatment of glioblastoma. [PDF]
Królikowska A, Tarnowski M.
europepmc +1 more source
MBNL loss facilitates resistance to T cell infiltration in vivo.
Austin M. Gabel (15162431) +7 more
openalex +1 more source
NAD+ Released during Inflammation Participates in T Cell Homeostasis by Inducing ART2-Mediated Death of Naive T Cells In Vivo [PDF]
Sahil Adriouch +5 more
openalex +1 more source
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.
C. Turtle +22 more
semanticscholar +1 more source
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert +13 more
wiley +1 more source
In vivo engineering of CAR-T cells: delivery strategies and clinical translation. [PDF]
Gao Y, Hu J, An N, Wen X, Li C.
europepmc +1 more source

